Navigation Links
FASEB joins President Obama in urging Congress to sustain investments in research and innovation
Date:2/13/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) enthusiastically supports President Barack Obama's call to Congress to maintain key federal investments in research and development as outlined in his State of the Union address last night. "Once again we sincerely appreciate the President's emphasis on scientific innovation and his willingness to make funding for research a national priority. We should not sacrifice our commitment to the research that has dramatically improved the quality of life for Americans and people around the world," stated Judith S. Bond, PhD, FASEB President.

FASEB also praised the President's emphasis on increasing investments in science and innovation. President Obama said, "Now is not the time to gut these job-creating investments in science and innovation. Now is the time to reach a level of research and development not seen since the height of the Space Race." In addition, the President noted that the automatic spending cuts known as sequestration would devastate priorities like education, energy, and medical research. "We will continue our advocacy efforts to urge Congress to sustain federal funding for the National Institutes of Health, the National Science Foundation, and the other research agencies," said Dr. Bond. Scientists and researchers from around the country have already sent nearly 20,000 emails to Capitol Hill in response to e-action alerts issued by FASEB. "I urge everyone in the scientific community to contact their members of Congress today and forward the FASEB alert to their colleagues," added the FASEB President.


'/>"/>

Contact: Lawrence Green
lgreen@faseb.org
301-634-7335
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
2. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
3. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
4. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
5. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
6. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
7. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
8. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
9. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
10. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
11. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/29/2019)... ... 29, 2019 , ... Fujirebio Diagnostics, Inc., a consolidated subsidiary ... of the company’s Lumipulse® G whole PTH Assay for testing on its LUMIPULSE® ... parathyroid glands; which are four small glands located behind the thyroid gland. The ...
(Date:10/26/2019)... FRANCISCO (PRWEB) , ... October 23, 2019 , ... ... Operating Officer, Christina Hughes , to its executive leadership team. , As ... integrated technology solutions allow growth-stage biotech and pharma companies to reduce timelines and ...
(Date:10/26/2019)... ... October 24, 2019 , ... THE PRINCESS VEST, Made ... the standard choice for female providers, they were the only choice. Women in radiology ... or a loose garment that can allow harmful radiation to penetrate the sides of ...
Breaking Biology News(10 mins):
(Date:10/26/2019)... ... October 24, 2019 , ... ... Bichsel Medical Marketing Group (BMMG), a boutique healthcare-specific marketing firm, to strengthen ... its in-house Healthcare Strategy Division. , Healthcare clients in pharma, bio-therapeutics, medical device ...
(Date:10/22/2019)... ... October 22, 2019 , ... DermBiont, ... its lead program, DBI-001, met its primary safety endpoints, with no application site ... clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the ...
(Date:10/10/2019)... NORTH BETHESDA, Md. (PRWEB) , ... October 09, ... ... (ISPE) announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a ... taking place 27–30 October 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, ...
(Date:10/8/2019)... Calif. (PRWEB) , ... October 08, 2019 , ... ... Master’s Project (TMP), Madhumita Suresh and Leslie Maurer presented company executives with a ... Business and Science (MBS) graduates will offer insights from their TMP to a ...
Breaking Biology Technology: